Mepolizumab in Episodic Angioedema With Eosinophilia
Conditions: Eosinophilia; Angioedema Intervention: Biological: Nucala (mepolizumab) Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials